Problem Based Learning in HBV: Improving Decisions to Optimize Outcomes
Symposium Date: Wednesday, March 29, 2017San Diego, CA Convention Center - Wednesday March 29, 2017
This activity offers CE credit for:
%>- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Thursday, March 29, 2018
Note: Credit Is No Longer Available
Kris V. Kowdley, MD, FACP, FACG, AGAF, FAASLD, (Moderator) Director, Liver Institute Northwest Clinical Professor, Elson S. Floyd College of Medicine Washington State University Seattle, WA |
Su Wang, MD, MPH, FACP Medical Director, Viral Hepatitis Programs and Center for Asian Health Cooperman Barnabas Medical Center, RJWBarnabas Health Livingston, NJ |
Hepatitis B virus (HBV) infection is a largely undetected and untreated disease in the United States despite the availability of screening guidelines and prophylactic vaccines. Chronic HBV infection causes severe complications, including cirrhosis and hepatocellular carcinoma in 20% - 30% of patients. As a result, HBV infection is the most common reason for liver transplantation.(1)
While recommendations exist, primary care providers are not adequately screening at-risk patients for HBV infection and many adults remain undiagnosed. Once identified, linking HBV patients from community clinics to proper care requires that clinicians be aware of optimal treatment plans based on lab results.
In this CME Outfitters live symposium, expert faculty will combine a didactic lecture with state-of-the-art technology to present a patient simulation with real-time decision-making, creating a small-group learning environment in a large-group setting.
- U.S. Department of Health and Human Services [HHS]. Action plan for the prevention, care, & treatment of viral hepatitis 2014-2016. HHS Website. http://aids.gov/pdf/viral-hepatitis-action-plan.pdf. Published February, 2014.
At the end of this CE activity, participants should be able to:
- Increase the rate at which clinicians appropriately screen at-risk patients for HBV.
- Develop a treatment strategy for patients who test positive for HBV to ensure they are referred and monitored for optimal care.
- Integrate a team-based care model for patients who test positive for HBV to monitor adherence to therapy.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Explain how to appropriately screen at-risk patients for HBV.
- Identify a treatment strategy for patients who test positive for HBV to ensure they are referred and monitored for optimal care.
- Describe a team-based care model for patients who test positive for HBV to monitor adherence to therapy.
Supported by an educational grant from Gilead Sciences, Inc.
Physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals managing in HBV infection.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1 contact hours
Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 1 contact hours of pharmacotherapeutic contact hours.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1 contact hours (0.10 CEUs) Universal Activity Number:
0376-0000-17-005-L01-P
Type: knowledge-based practice-based
CME Outfitters, LLC, designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, have evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Kowdley has nothing to disclose.
Dr. Wang has nothing to disclose.
Tony Graham, MD (peer reviewer) has nothing to disclose
Kimberley Murray, RN, MS (peer reviewer) has nothing to disclose
Kashemi D. Rorie, PhD (planning committee) has nothing to disclose.
Sharon Tordoff, CHCP (planning committee) has nothing to disclose.
Disclosures were obtained from the CME Outfitters, LLC staff: Nothing to disclose.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
MM-067-032917-47